premature%20ejaculation
PREMATURE EJACULATION
Premature ejaculation is a male sexual dysfunction characterized by short, easily stimulated ejaculation that occurs always or nearly always before or within one minute of vaginal penetration.
It is involuntarily controlled and causes negative personal consequences like distress, frustration and avoidance of sexual intimacy.
Exact etiology and risk factors are unknown.
  1. Althof SE, Abdo CH, Dean J, et al. International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med. 2010 Sep;7(9):2947-2969. doi: 10.1111/j.1743-6109.2010.01975.x. PMID: 21050394
  2. Althof SE, McMahon CG, Waldinger MD, et al. An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med. 2014 Jun;11(6):1392-1422. doi: 10.1111/jsm.12504. PMID: 24848686
  3. Hatzimouratidis K, Amar E, Eardley I, et al. European Association of Urology guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Urology. 2010;57:804-814. doi: 10.1016/j.eururo.2010.02.020. PMID: 20189712
  4. Hatzimouratidis K, Eardley I, Giuliano F, et al. European Association of Urology guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. 2015 Mar:1-53.
  5. Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the pharmacologic management of premature ejaculation.. J Urol. 2004 Jul;172(1):290-294. http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines/main-reports/pme/pme_2004.pdf. PMID: 15201797
  6. Mulhall JP. Premature ejaculation. In: Wein AJ, ed. Campbell-Walsh Urology. 10th. Philadelphia, PA: Elsevier Saunders; 2011:770-779.
  7. Society for Men’s Health (Singapore). MIMS guidelines on premature ejaculation by Society for Men’s Health (Singapore). MIMS; 2014:1-9.
  8. Symonds T, Perelman MA, Althof S, et al. European Association of Urology development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007 Aug;52(2):565-573. http://www.ncbi.nlm.nih.gov/pubmed/17275165. PMID: 17275165
  9. Hatzimouratidis K, Salonia A, Giuliano, et al. European Association of Urology guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. UroWeb. www.uroweb.org. 2017.
  10. El-Hamd MA, Saleh R, Majzoub A. Premature ejaculation: an update on definition and pathophysiology. Asian J Androl. 2019 Mar. doi: 10.4103/aja.aja_122_18. PMID: 30860082
  11. Chung E, Gilbert B, Perera M, et al. Premature ejaculation: a clinical review for the general physician. Aust Fam Physician. 2015 Oct;44(10):737-743. PMID: 26484490
  12. Hatzimouratidis K, Guiliano F, Moncada I, et al. EAU guidelines on erectile dysfunction, premature ejaculation, penile curvature and priapism. European Association of Urology. https://uroweb.org. Mar 2016.
  13. Khera M, Cunningham GR. Treatment of male sexual dysfunction. UpToDate. https://www.uptodate.com. Oct 2018. Accessed 24 Jul 2019.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Hannah Wong, 30 Sep 2019

Taisho Pharmaceutical launches Lusefi®, an oral anti-diabetic medication for type 2 diabetes mellitus (T2DM). The medication is expected to lower blood glucose and provide adequate glycaemic control, serving as a new alternative prescription for T2DM. Lusefi, with its active ingredient luseogliflozin hydrate, is available in the form of 2.5 mg and 5 mg tablets.

02 May 2019
At a recent Abbott lunch symposium held in conjunction with the joint 12th International Diabetes FederationWestern Pacific Region Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in KualaLumpur, Professor Shashank R. Joshi extensively discussed the issue of diabetes in obesity and the role of nutritionalintervention in addressing this growing problem.
Tristan Manalac, 19 Nov 2019
Dapagliflozin is able to delay renal disease progression among patients with type 2 diabetes, even in those with normal kidney function, according to a study presented at the recently concluded Kidney Week 2019 of the American Society of Nephrology (ASN 2019).
07 Oct 2019
In pancreatic cancer patients undergoing chemotherapy, the presence of diabetes mellitus is associated with reduced survival and larger tumour, as well as with increased risk of death after treatment, according to a meta-analysis.